Erik Tambuyzer
Direttore/Membro del Consiglio presso Augustine Therapeutics NV
Posizioni attive di Erik Tambuyzer
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Augustine Therapeutics NV
 Augustine Therapeutics NV Medical/Nursing ServicesHealth Services Augustine Therapeutics NV is a Belgian company that focuses on developing innovative therapies for neuromuscular and neurodegenerative diseases. The company is based in Leuven, Belgium. The company's main focus is on HDAC6, a class II histone deacetylase, which is a well-known molecular target in various diseases, particularly neurodegenerative disorders and neuropathies. The company was founded in 2019, and Sylvain Celanire has been the CEO of the company since 2020. | Direttore/Membro del Consiglio | 19/03/2021 | - |
Storia della carriera di Erik Tambuyzer
Formazione di Erik Tambuyzer
| Katholieke Universiteit Leuven | Doctorate Degree |
Statistiche
Distribuzione geografica
| Belgio | 3 |
Posizioni
| Director/Board Member | 1 |
| Doctorate Degree | 1 |
Settori
| Health Services | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Augustine Therapeutics NV
Augustine Therapeutics NV Medical/Nursing ServicesHealth Services Augustine Therapeutics NV is a Belgian company that focuses on developing innovative therapies for neuromuscular and neurodegenerative diseases. The company is based in Leuven, Belgium. The company's main focus is on HDAC6, a class II histone deacetylase, which is a well-known molecular target in various diseases, particularly neurodegenerative disorders and neuropathies. The company was founded in 2019, and Sylvain Celanire has been the CEO of the company since 2020. | Health Services |
- Borsa valori
- Insiders
- Erik Tambuyzer
- Esperienza
